Friday, 25 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 28, 2026

United States AI in Healthcare Market Forecast Report and Company Analysis 2025-2033 Featuring AWS, General Vision, Google, Intel, Medtronic, Micron, Microsoft, Next IT, NVIDIA, Siemens Healthcare

View original at finance.yahoo.com
United States AI in Healthcare Market Forecast Report and Company Analysis 2025-2033 Featuring AWS, General Vision, Google, Intel, Medtronic, Micron, Microsoft, Next IT, NVIDIA, Siemens Healthcare Company Logo The United States AI in Healthcare Market is projected to soar from US$ 10.26 billion in 2025 to US$ 99.77 bil…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • California, Texas, New York, and Florida lead in AI healthcare adoption, bolstering U.S. AI healthcare innovation.

    80% confidence
  • The high cost of implementing AI technologies and the shortage of skilled professionals pose significant barriers to market growth.

    80% confidence
  • The United States is becoming a global leader in healthcare innovation as a result of the acceleration of AI integration brought about by rising healthcare costs and the expansion of big data availability.

    80% confidence
  • One of the major challenges in the U.S. AI in Healthcare market is ensuring data privacy and compliance with complex regulations such as HIPAA and emerging state-specific laws.

    80% confidence
  • The FDA's support for AI-based medical devices and government programs encouraging healthcare digitization further accelerate industry growth.

    80% confidence
  • NLP advancements are accelerating AI adoption across the U.S. healthcare sector by transforming how unstructured clinical data is utilized.

    80% confidence
  • AI-powered precision medicine platforms are being deployed across oncology, neurology, and cardiology to identify molecular markers and optimize care delivery.

    80% confidence
  • Rapid digital transformation, growing demand for precision medicine, robust government support, and the need for affordable healthcare solutions are the main factors propelling the U.S. AI in healthcare market.

    80% confidence
  • Many small and mid-sized hospitals struggle to afford AI technologies, leading to uneven adoption across regions.

    80% confidence
  • The United States AI in Healthcare Market is expected to reach US$ 99.77 billion by 2033 from US$ 10.26 billion in 2025, with a CAGR of 32.88% from 2025 to 2033.

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com